EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $216,000 | -27.3% | 5,251 | 0.0% | 0.07% | -26.1% |
| Q2 2021 | $297,000 | -34.7% | 5,251 | -71.8% | 0.09% | -47.4% |
| Q1 2019 | $455,000 | +6.6% | 18,629 | -0.8% | 0.18% | -5.4% |
| Q4 2018 | $427,000 | -28.6% | 18,787 | 0.0% | 0.18% | -13.1% |
| Q3 2018 | $598,000 | -11.1% | 18,787 | 0.0% | 0.21% | -8.2% |
| Q2 2018 | $673,000 | +8.0% | 18,787 | 0.0% | 0.23% | +9.4% |
| Q1 2018 | $623,000 | -18.2% | 18,787 | -24.2% | 0.21% | -18.5% |
| Q4 2017 | $762,000 | +27.6% | 24,787 | -0.3% | 0.26% | +19.8% |
| Q3 2017 | $597,000 | +43.2% | 24,859 | 0.0% | 0.22% | +46.6% |
| Q2 2017 | $417,000 | -27.1% | 24,859 | -3.0% | 0.15% | -24.9% |
| Q1 2017 | $572,000 | +149.8% | 25,616 | +173.5% | 0.20% | +107.4% |
| Q2 2016 | $229,000 | – | 9,366 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |